idrabiotaparinux
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The introduction of factor Xa inhibitors advocated the initiation of clinical trials that addressed the value of anticoagulation…
Background Venous thromboembolism (VTE) is a prevalent disease with potential serious consequences. Idraparinux and…
In recent years, the significant limitations associated with the use of vitamin K antagonists (VKA) have encouraged the…
Idraparinux, an analogue of fondaparinux, was a promising parenteral factor Xa inhibitor with a prolonged elimination half-life…
The association between cancer and venous thromboembolism (VTE) has been well documented in the literature. Prevention and…
Idraparinux is a polymethylated synthetic pentasaccharide that binds to antithrombin with high affinity. Idrabiotaparinux is a…
Anticoagulation is recommended for prophylaxis and treatment of venous thromboembolism (VTE) (deep vein thrombosis and pulmonary…
Idrabiotaparinux is a novel synthetic anticoagulant that links idraparinux, a specific, indirect factor Xa inhibitor, to biotin…